» Articles » PMID: 35648219

Role of the Soluble Epoxide Hydrolase in the Hair Follicle Stem Cell Homeostasis and Hair Growth

Overview
Journal Pflugers Arch
Specialty Physiology
Date 2022 Jun 1
PMID 35648219
Authors
Affiliations
Soon will be listed here.
Abstract

Polyunsaturated fatty acids (PUFAs) are used as traditional remedies to treat hair loss, but the mechanisms underlying their beneficial effects are not well understood. Here, we explored the role of PUFA metabolites generated by the cytochrome P450/soluble epoxide hydrolase (sEH) pathway in the regulation of the hair follicle cycle. Histological analysis of the skin from wild-type and sEH mice revealed that sEH deletion delayed telogen to anagen transition, and the associated activation of hair follicle stem cells. Interestingly, EdU labeling during the late anagen stage revealed that hair matrix cells from sEH mice proliferated at a greater rate which translated into increased hair growth. Similar effects were observed in in vitro studies using hair follicle explants, where a sEH inhibitor was also able to augment whisker growth in follicles from wild-type mice. sEH activity in the dorsal skin was not constant but altered with the cell cycle, having the most prominent effects on levels of the linoleic acid derivatives 12,13-epoxyoctadecenoic acid (12,13-EpOME), and 12,13-dihydroxyoctadecenoic acid (12,13-DiHOME). Fitting with this, the sEH substrate 12,13-EpOME significantly increased hair shaft growth in isolated anagen stage hair follicles, while its diol; 12,13-DiHOME, had no effect. RNA sequencing of isolated hair matrix cells implicated altered Wnt signaling in the changes associated with sEH deletion. Taken together, our data indicate that the activity of the sEH in hair follicle changes during the hair follicle cycle and impacts on two stem cell populations, i.e., hair follicle stem cells and matrix cells to affect telogen to anagen transition and hair growth.

Citing Articles

The Octadecanoids: Synthesis and Bioactivity of 18-Carbon Oxygenated Fatty Acids in Mammals, Bacteria, and Fungi.

Revol-Cavalier J, Quaranta A, Newman J, Brash A, Hamberg M, Wheelock C Chem Rev. 2024; 125(1):1-90.

PMID: 39680864 PMC: 11719350. DOI: 10.1021/acs.chemrev.3c00520.


Role of the soluble epoxide hydrolase in keratinocyte proliferation and sensitivity of skin to inflammatory stimuli.

Naeem Z, Zukunft S, Huard A, Hu J, Hammock B, Weigert A Biomed Pharmacother. 2024; 171:116127.

PMID: 38198951 PMC: 10857809. DOI: 10.1016/j.biopha.2024.116127.

References
1.
Atone J, Wagner K, Hashimoto K, Hammock B . Cytochrome P450 derived epoxidized fatty acids as a therapeutic tool against neuroinflammatory diseases. Prostaglandins Other Lipid Mediat. 2019; 147:106385. PMC: 7067627. DOI: 10.1016/j.prostaglandins.2019.106385. View

2.
Dos Santos L, Fleming I . Role of cytochrome P450-derived, polyunsaturated fatty acid mediators in diabetes and the metabolic syndrome. Prostaglandins Other Lipid Mediat. 2020; 148:106407. DOI: 10.1016/j.prostaglandins.2019.106407. View

3.
Imig J . Prospective for cytochrome P450 epoxygenase cardiovascular and renal therapeutics. Pharmacol Ther. 2018; 192:1-19. PMC: 6263841. DOI: 10.1016/j.pharmthera.2018.06.015. View

4.
Fleming I . The pharmacology of the cytochrome P450 epoxygenase/soluble epoxide hydrolase axis in the vasculature and cardiovascular disease. Pharmacol Rev. 2014; 66(4):1106-40. DOI: 10.1124/pr.113.007781. View

5.
McReynolds C, Morisseau C, Wagner K, Hammock B . Epoxy Fatty Acids Are Promising Targets for Treatment of Pain, Cardiovascular Disease and Other Indications Characterized by Mitochondrial Dysfunction, Endoplasmic Stress and Inflammation. Adv Exp Med Biol. 2020; 1274:71-99. PMC: 7737916. DOI: 10.1007/978-3-030-50621-6_5. View